From Intervention to Innovation: dTIP’s Exciting New Chapter
In an exclusive interview, Ivo Schauwecker, Managing Director of dTIP, shares the vision behind the platform’s rebranding to “Digital Trial Innovation Platform” and what lies ahead.
“The new name reflects our broader vision and support offered to ETH researchers,” Ivo explains. “We’re not just about intervention anymore; we’re harnessing the power of digital tools to transform human research, making them more efficient and impactful.”
As human research faces growing challenges, from data privacy to patient recruitment, dTIP is staying ahead by investing in secure, patient-centric digital solutions. “We’re committed to improving data security, user experience, and staying compliant with ever-evolving regulations,” says Ivo.
Partnerships are another cornerstone of dTIP’s strategy. “Collaborating with ETH researchers, spin-offs, startups, and other research organizations allows us to support a variety of needs, from clinical evidence generation to navigating regulatory landscapes,” Ivo emphasizes.
For researchers, dTIP offers a comprehensive suite of services, including clinical trials, study coordination, monitoring, data management, and regulatory consulting. “We’re here to streamline their work and help translating their innovations to life,” Ivo concludes.
Discover our services